Alume Biosciences, Inc.   Report issue

For profit Phase 2
Founded: San Diego CA United States (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
2020
NCT04420689
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Alume Biosciences, Inc.